Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines

References

• Adamska K, Voelkel A, Héberger K. 2007. Selection of solubility parameters for characterization of pharmaceutical excipients. J Chromatogr A. 1171:90–97.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S. 2005. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Bagchi D, Preuss HG, editors. Phytopharmaceuticals in cancer chemoprevention. Boca Raton: CRC Press; p. 349–387.
   Google Scholar
• Andreani T, Kiill CP, Souza ALRd, Fangueiro JF, Fernandes L, Doktorovová S, Santos DL, Garcia ML, Gremião MPD, Souto EB, et al. 2014. Surface engineering of silica nanoparticles for oral insulin delivery: Characterization and cell toxicity studies. Colloids Surf B Biointerfaces. 123:916–923.
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M, Rytting E, Lebhardt T, Wang X, Kissel T. 2010. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the ‘ouzo region’ upon drug loading. Eur JPharm Sci. 41:244–253.
   PubMed Web of Science ®Google Scholar
• Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BV, Khar A. 1999. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett. 456:311–314.
   PubMed Web of Science ®Google Scholar
• Bondi ML, Craparo E, Picone FP, Carlo MD, Gesu R, Capuano D, Giammona GG. 2010. Curcumin entrapped into lipid nanosystems inhibits neuroblastoma cancer cell growth and activates Hsp70 protein. Curr Nanosci. 6:439–445.
   Web of Science ®Google Scholar
• Braem C, Blaschke T, Panek-Minkin G, Herrmann W, Schlupp P, Paepenmüller T, Müller-Goyman C, Mehnert W, Bittl R, Schäfer-Korting M, Kramer KD. 2007. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release. 119:128–135.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhong Z, Xu Z, Chen L, Wang Y. 2010. 2′,7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic Res. 44:587–604.
   PubMed Web of Science ®Google Scholar
• Chirio D, Gallarate M, Peira E, Battaglia L, Serpe L, Trotta M. 2011. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul. 28:537–548.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Kovačević AB, Garcia ML, Souto EB. 2016. Pre-clinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 108:235–252.
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Santos DL, Costa I, Andreani T, Souto EB, Silva AM. 2014. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells. Int J Pharm. 471:18–27.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Shegokar R, Rakovsky E, Gonzalez-Mira E, Lopes CM, Silva AM, Martins-Lopes P, Muller RH, Souto EB. 2011. Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies. Int J Pharm. 420:341–349.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB, Silva AM. 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data. Eur J Pharm Biopharm. 87:1–18.
   PubMed Web of Science ®Google Scholar
• Fang J, Lu J, Holmgren A. 2005. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem. 280:25284–25290.
   PubMed Web of Science ®Google Scholar
• Goel A, Boland CR, Chauhan DP. 2001. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 172:111–118.
   PubMed Web of Science ®Google Scholar
• Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG. 2010. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem. 58:2095–2099.
   PubMed Web of Science ®Google Scholar
• Hanif R, Qiao L, Shiff SJ, Rigas B. 1997. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med. 130:576–584.
   PubMed Web of Science ®Google Scholar
• Hansen CM. 2007. Hansen solubility parameters: a user's handbook. 2nd ed. Boca Raton (FL): CRC Press.
   Google Scholar
• Hazzah HA, Farid RM, Nasra MM, Zakaria A, Gawish MY, El-Massik MA, Abdallah OY. 2016. A new approach for treatment of precancerous lesions with curcumin solid–lipid nanoparticle-loaded gels: in vitro and clinical evaluation. Drug Deliv. 23:1409–1419.
   PubMed Web of Science ®Google Scholar
• Heger M, van Golen R, Broekgaarden FM, Michel MC. 2014. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharm Rev. 66:222–307.
   PubMed Web of Science ®Google Scholar
• Joe B, Lokesh BR. 1994. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta. 1224:255–263.
   PubMed Web of Science ®Google Scholar
• Kakkar V, Kaur IP. 2011. Evaluating potential of curcumin loaded solid lipid nanoparticles in Aluminium induced behavioral, biochemical and histopathological alterations in mice brain. Food Chem Toxicol. 49:2906–2913.
   PubMed Web of Science ®Google Scholar
• Kakkar V, Mishra AK, Chuttani K, Kaur IP. 2013. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. Int J Pharm. 448:354–359.
   PubMed Web of Science ®Google Scholar
• Kim S, Diab R, Joubert O, Canilho N, Pasc A. 2016. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin. Colloids Surf B Biointerfaces. 140:161–168.
   PubMed Web of Science ®Google Scholar
• Kovačević A. 2014. Lipidne nanočestice stabilizovane nejonskim polihidroksilnim surfaktantima: postupak dobijanja, karakterizacija, stabilnost i inkorporiranje lekovite supstance. Belgrade, Serbia: University of Belgrade, p. 159–162.
   Google Scholar
• Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD. 2009. Nanoparticles for skin penetration enhancement – A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm. 71:243–250.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Dillon SP, Dorri Y, D'Souza A, Scofield RH. 2011. Curcumin does not bind or intercalate into DNA and a note on the gray side of curcumin. Int J Cancer. 128:242–245.
   PubMed Web of Science ®Google Scholar
• Lai HW, Chien SY, Kuo SJ, Tseng LM, Lin HY, Chi CW, Chen DR. 2012. The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin. Evid Based Complement Alternat Med. 2012:486568.
   PubMedGoogle Scholar
• Lin JK, Pan MH, Lin-Shiau SY. 2000. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors. 13:153–158.
   PubMed Web of Science ®Google Scholar
• LiTaulier Y, Rauth N, Wu AX. 2006. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharma Res. 23:1877–1887.
   Google Scholar
• Martins S, Costa-Lima S, Carneiro T, Cordeiro-da-Silva A, Souto EB, Ferreira DC. 2012. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int J Pharm. 430:216–227.
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Reimold I, Fricker G, Souto E, Ferreira D, Brandl M. 2012. Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies. Int J Pharm. 439:49–62.
   PubMed Web of Science ®Google Scholar
• Mitchell TM. 2003. Correspondence re: Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. 2002. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 62:3868–3875. Cancer Res. 63:5165–5166; author reply 5166–5167.
   Google Scholar
• Moos PJ, Edes K, Mullally JE, Fitzpatrick FA. 2004. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis. 25:1611–1617.
   PubMed Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, Mahadik KR, Paradkar AR. 2010. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 398:190–203.
   PubMed Web of Science ®Google Scholar
• Muller R, Shegokar R, Keck C. 2011. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol. 8:207–227.
   PubMedGoogle Scholar
• Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. 2014. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 35:3365–3383.
   PubMed Web of Science ®Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. 2010. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces. 81:263–273.
   PubMed Web of Science ®Google Scholar
• Noack A, Hause G, Mader K. 2012. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm. 423:440–451.
   PubMed Web of Science ®Google Scholar
• Pawar H, Surapaneni S, Tikoo K, Singh K, Burman CR, Gill M, Suresh SS. 2016. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats. Drug Deliv. 23:1453–1468.
   PubMed Web of Science ®Google Scholar
• Pawar YB, Purohit H, Valicherla GR, Munjal B, Lale SV, Patel SB, Bansal AK. 2012. Novel lipid based oral formulation of curcumin: Development and optimization by design of experiments approach. Int J Pharm. 436:617–623.
   PubMed Web of Science ®Google Scholar
• Puglia C, Frasca G, Musumeci T, Rizza L, Puglisi G, Bonina F, Chiechio S. 2012. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice. Eur J Pharm Biopharm. 81:288–293.
   PubMed Web of Science ®Google Scholar
• Salaün F, Vroman I. 2009. Curcumin-loaded nanocapsules: formulation and influence of the nanoencapsulation processes variables on the physico-chemical characteristics of the particles. Int J Chem Reactor Eng. 7.
   Web of Science ®Google Scholar
• Salminen H, Gömmel C, Leuenberger BH, Weiss J. 2016. Influence of encapsulated functional lipids on crystal structure and chemical stability in solid lipid nanoparticles: Towards bioactive-based design of delivery systems. Food Chem. 190:928–937.
   PubMed Web of Science ®Google Scholar
• Santos IS, Ponte BM, Boonme P, Silva AM, Souto EB. 2013. Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer. Biotechnol Adv. 31:514–523.
   PubMed Web of Science ®Google Scholar
• Shah M, Agrawal Y. 2013. High throughput screening: an in silico solubility parameter approach for lipids and solvents in SLN preparations. Pharm Dev Technol. 18:582–590.
   PubMed Web of Science ®Google Scholar
• Shah MK, Madan P, Lin S. 2014. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. Pharm Dev Technol. 19:475–485.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, Steward WP. 2005. Curcumin: the story so far. Eur J Cancer. 41:1955–1968.
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. 2002. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 62:3868–3875.
   PubMed Web of Science ®Google Scholar
• Souto EB, Mehnert W, Müller RH. 2006. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul. 23:417–433.
   PubMed Web of Science ®Google Scholar
• Souza ALRd, Andreani T, de Oliveira RN, Kiill CP, Santos FKd, Allegretti SM, Chaud MV, Souto EB, Silva AM, Gremião MPD. 2014. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment. Int J Pharm. 463:31–37.
   PubMed Web of Science ®Google Scholar
• Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. 2013. Curcumin-loaded solid lipid nanoparticles have prolonged in-vitro antitumour activity, cellular uptake and improved in-vivo bioavailability. Colloids Surf B: Biointerfaces. 111:367–375.
   PubMed Web of Science ®Google Scholar
• Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G. 2012. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine (Lond). 7:1085–1100.
   PubMed Web of Science ®Google Scholar
• Vallianou N, Evangelopoulos G, Schizas A, Kazazis NC. 2015. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 35:645–651.
   PubMed Web of Science ®Google Scholar
• Vandita K, Shashi B, Santosh KG, Pal KI. 2012. Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles. Mol Pharm. 9:3411–3421.
   PubMed Web of Science ®Google Scholar
• van Krevelen D, te Nijenhuis WK. 2009. Cohesive properties and solubility in: properties of polymers: Their correlation with chemical structure; their numerical estimation and prediction from additive group contributions, properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. Amsterdam, The Netherlands: Elsevier Science; p. 189–228.
   Google Scholar
• WangZhu W, Xie R, Li Q, Xiao A, Li Y, Liu K, Cui H, Chen D, Wang YS. 2012. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine. 7:3667–3677.
   PubMed Web of Science ®Google Scholar
• Wasutrasawat P, Al-Obaidi H, Gaisford S, Lawrence MJ, Warisnoicharoen W. 2013. Drug solubilisation in lipid nanoparticles containing high melting point triglycerides. Eur J Pharm Biopharm. 85:365–371.
   PubMed Web of Science ®Google Scholar
• Yuan T, Qin L, Wang Z, Nie J, Guo Z, Li G, Wu C. 2013. Solid lipid dispersion of calcitriol with enhanced dissolution and stability. Asian J Pharm Sci. 8:39–47.
   Google Scholar